Clinical trial
A Single Arm Study of SNX-5422 in Subjects With TP53 Null Cancers
NCT02612285 is registered in ClinicalTrials.gov with Esanex Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single Arm Study of SNX-5422 in Subjects With TP53 Null Cancers
- Lead sponsor
- Esanex Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2016
- Completion date
- October 31, 2016
- Enrollment
- 1 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cancer